Tscan Therapeutics, Inc. · NASDAQ:TCRX

BVF PARTNERS L P/IL reported a 9.99% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Tscan Therapeutics, Inc., 5,578,288 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
5,578,288
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.40%3,014,267
BVF I GP LLC5.40%3,014,267
BIOTECHNOLOGY VALUE FUND II LP3.30%1,868,548
BVF II GP LLC3.30%1,868,548
Biotechnology Value Trading Fund OS LP1.00%560,400
BVF Partners OS Ltd.1.00%560,400
BVF GP HOLDINGS LLC8.70%4,882,815
BVF PARTNERS L P/IL9.99%5,578,288
BVF INC/IL9.99%5,578,288
LAMPERT MARK N9.99%5,578,288

Source

View original at SEC

Related